Suchergebnisse
City Holding (CHCO) Could Be a Great Choice
All investors love getting big returns from their portfolio, whether it's through stocks, bonds, ETFs, or other types of securities. But for income investors, generating consistent cash flow from
TYL to Report Q2 Earnings: What's in the Cards for the Stock?
Tyler Technologies, Inc. TYL is scheduled to report second-quarter 2026 results on July 29, 2026, after market close.
The Zacks Consensus Estimate for second-quarter revenues is pegged at $647
Ford, PACCAR, OSK & ABG: Can They Beat Q2 Earnings Estimates?
We are in the heart of the second-quarter earnings season for the Auto-Tires-Trucks sector, with several auto companies set to report results this week. So far, three S&P 500 sector components —
Can 5G Tailwinds Help These 3 Wireless Stocks Beat Estimates?
Accelerated 5G deployments are expected to enhance the telecommunications industry's scalability, security and mobility while driving the broader adoption of Internet of Things (IoT) applications
Vertex Gears Up to Report Q2 Earnings: What Can Investors Expect?
Vertex Pharmaceuticals VRTX is scheduled to report its second-quarter 2026 results on Aug. 3, after market close. The Zacks Consensus Estimate for the to-be-reported quarter’s revenues is pegged at
Can Walmart Sustain Gains Among Higher-Income Customers?
Walmart Inc. WMT is broadening its appeal beyond value-focused consumers as higher-income households respond to its mix of low prices, convenience and wider product selection. The sustainability of
TT Gears Up to Report Q2 Earnings: What's in the Cards?
Trane Technologies plc TT is set to report second-quarter 2026 earnings on July 30, before the opening bell.
The company’s earnings surprise history has been impressive. It surpassed the Zacks
ALGM to Report Q1 Earnings: What's in the Cards for the Stock?
Allegro MicroSystems ALGM is scheduled to report first-quarter fiscal 2027 results on July 30, 2026, after market close.
The Zacks Consensus Estimate for fiscal first-quarter revenues is pegged at
DTE Energy Gears Up to Report Q2 Earnings: What's in the Cards?
DTE Energy Company DTE is scheduled to release second-quarter 2026 results on July 28, before market open. The company delivered a negative earnings surprise of 1.52% in the last reported
Neurocrine Gears Up to Report Q2 Earnings: What's in the Cards?
Neurocrine Biosciences NBIX is scheduled to report second-quarter 2026 results on July 30, after market close. We expect investors to focus on the sales performance of NBIX’s marketed products and
CenterPoint Energy to Report Q2 Earnings: What's in the Cards?
CenterPoint Energy, Inc. CNP is slated to report second-quarter 2026 results on July 28, 2026, before market open. The company delivered a negative earnings surprise of 3.45% in the last reported
Can nVent Electric's $2.6B Backlog Drive Future Revenue Growth?
nVent Electric NVT entered 2026 with a strong order book that could support future revenue growth. The company ended the first quarter of 2026 with a record backlog of $2.6 billion, up in low double
IDEX Gears Up to Report Q2 Earnings: What's in the Cards?
IDEX Corporation IEX is scheduled to release second-quarter 2026 results on July 29, before market open.The Zacks Consensus Estimate for second-quarter earnings has decreased a penny in the past 60
Can Increasing HDD Exabyte Shipments Bolster Seagate's Q4 Earnings?
Seagate Technology Holdings plc STX is set to report fourth-quarter fiscal 2026 earnings on Wednesday, after the closing bell. In the quarter, the company is likely to have generated higher revenues
Kura Oncology Reports 50% Response Rate in RCC Combination Study
Key Points
- Interested in Kura Oncology, Inc.? Here are five stocks we like better.
- Kura Oncology reported encouraging efficacy signals for darlifarnib combined with cabozantinib in heavily
A $1.5 Billion Wake-Up Call for Every AI Company on Wall Street
Key Points
- Interested in Datavault AI Inc.? Here are five stocks we like better.
- A federal judge granted final approval to Anthropic's $1.5 billion settlement with authors, putting a real market
Is Immunocore Stock Attractive After Kimmtrak's Strong Sales Growth?
Immunocore Holdings IMCR gives investors a mixed setup. Kimmtrak sales are still growing, the balance sheet is substantial and the pipeline has several value-creating shots on goal.
The caution is
Immunocore's Kimmtrak Growth Story and Major 2026 Catalysts Ahead
Immunocore Holdings IMCR has built its commercial base around Kimmtrak, its only marketed product and a standard treatment for eligible metastatic uveal melanoma patients in most launched markets.
Why Investors Should Stay the Course as Google CAPEX Surges
Google Smashes EPS, Stock Falls
Last week, Zacks Rank #2 (Buy) company Alphabet (GOOGL) reported financial results that smashed Wall Street expectations. Total revenue jumped to ~$120 billion,
Is DAR Stock Attractive After a Strong Earnings and Margin Rebound?
Darling Ingredients Inc. DAR has a better operating story after a sharp first-quarter recovery, but the case is mixed.The shares combine stronger earnings, a discounted forward multiple and


